Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-05-14 @ 5:11 PM
Study NCT ID:
NCT05564650
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-08
First Post:
2022-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Sponsor:
Organization: